Torrent Pharmaceuticals is trading higher by 3.4% at Rs 498, extending its over 13% rally in past four days, after reporting 33% year-on-year (yoy) growth in adjusted net profit at Rs 149 crore for the second quarter ended September 2013 (Q2) due to higher operational income.
The company has reported a 25.8% yoy rise in net sales to Rs 940 crore on the back of a 31.3% yoy rise in the revenues from the international business partially contributed by currency benefits.
The operating profit margin (OPM) rose by 169 basis points yoy to 19.1% on a higher rupee realisation from international trade and a better product mix.
The company is in the process of expanding its formulation and active pharmaceutical ingredient (API) capacity at Dahej with an investment of Rs 1,100 crore which will help ramp up the product basket for the international markets, says analyst at Sharekhan in its report dated October 31.
The stock opened at Rs 493 and touched 52-week high of Rs 501 on BSE. A combined around 16,000 shares have changed hands on the counter so far on BSE and NSE.
The company has reported a 25.8% yoy rise in net sales to Rs 940 crore on the back of a 31.3% yoy rise in the revenues from the international business partially contributed by currency benefits.
The operating profit margin (OPM) rose by 169 basis points yoy to 19.1% on a higher rupee realisation from international trade and a better product mix.
The company is in the process of expanding its formulation and active pharmaceutical ingredient (API) capacity at Dahej with an investment of Rs 1,100 crore which will help ramp up the product basket for the international markets, says analyst at Sharekhan in its report dated October 31.
The stock opened at Rs 493 and touched 52-week high of Rs 501 on BSE. A combined around 16,000 shares have changed hands on the counter so far on BSE and NSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%